69
Participants
Start Date
November 28, 2007
Primary Completion Date
November 24, 2010
Study Completion Date
August 1, 2012
RDEA119
In the dose escalation phase, subjects will receive a single oral dose of RDEA119 on Day 1, wait 1 week, then begin a 28-day course of daily continuous dosing of RDEA119. In the expanded MTD phase, subjects will receive RDEA119 once or twice a day beginning on Day 1, and begin a 28-day course of continuous dosing at that time.
Roswell Park Cancer, Buffalo
UCHSC, Aurora
TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale
Lead Sponsor
Bayer
INDUSTRY